Back to the main directory
Company Analysis / Equity
- Morningstar | Moats for the U.S.-Based Asset Managers Are Narrowing; Stick With BlackRock and T. Rowe Price by Morningstar
- Morningstar | Moats for the U.S.-Based Asset Managers Are Narrowing; Stick With BlackRock and T. Rowe Price by Morningstar
- Menu Changes, Streamlined Operations, and Off-Premises Sales Make Darden a Casual Dining Standout by Morningstar
- Dick's Invests in E-Commerce, Private Label, and In-Store Experiences as It Prepares for Growth by Morningstar
- Morningstar | Equifax Struggles for Growth in 1Q, Makes Progress on Resolving Breach Settlements by Morningstar
- Lowering Our FVE for No-Moat Exelixis to $24 Per Share After Fresh Look at Cabozantinib Franchise by Morningstar
- Morningstar | Moats for the U.S.-Based Asset Managers Are Narrowing; Stick With BlackRock and T. Rowe Price by Morningstar
- Morningstar | Moats for the U.S.-Based Asset Managers Are Narrowing; Stick With BlackRock and T. Rowe Price by Morningstar
- Morningstar | Humana's Dominant Presence in Medicare Advantage Is Deserving of a Narrow Economic Moat by Morningstar
- Morningstar | Integra's 1Q Results Meet Expectations, but Growth Needs to Accelerate to Achieve Full-Year Outlook by Morningstar
- KeyCorp's Tough 1Q Raises Concerns About Revenue Growth by Morningstar
- Morningstar | Singapore Expansion Supports Sands' Brand Advantage and Japanese Gaming License Potential by Morningstar
- Morningstar | Rate Cuts Present Surmountable Headwinds For M&T; FVE $154 by Morningstar
- Morningstar | Nice-ly Positioned With Clear Product Road Map and More Predictable Revenue; Raising FVE to $130. See Updated Analyst Note from 09 Apr 2019 by Morningstar
- Morningstar | Wide-Moat Nike’s Edge Unwavering, Despite Intense Competitive Pressures Around the World by Morningstar
- Despite Strong Near-Term Results for U.K. Unit, Long Term Remains a Significant Concern by Morningstar
- We Assign Raytheon a Wide Economic Moat and a $213 Fair Value Estimate by Morningstar
- Morningstar | Strong U.S. Carrier Spending Continues to Drive Excellent SBA Results, and We Project It to Persist by Morningstar
- Morningstar | Initiating on Fast-Growing Cannabis Industry: We See Scotts Miracle-Gro as Slightly Overvalued by Morningstar
- Steris' Narrow Economic Moat Supported By Elevated Investment in Fiscal 2020 by Morningstar
- Morningstar | Stratasys Starts 2019 in the Right Direction, but With Many Unanswered Questions; Maintaining FVE by Morningstar
- Morningstar | Pharmaceutical and Biotech Channel Continues to Deliver for Thermo Fisher by Morningstar
- Morningstar | Union Pacific Implements Network Wide Precision Scheduled Railroading in a Soft Demand Environment by Morningstar
- Morningstar | Moats for the U.S.-Based Asset Managers Are Narrowing; Stick With BlackRock and T. Rowe Price by Morningstar
- Ferguson's 3Q Shows Softening in U.S. Demand As Expected; Shares Fairly Valued by Morningstar